Copyright
©The Author(s) 2021.
World J Clin Oncol. Jun 24, 2021; 12(6): 404-428
Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.404
Published online Jun 24, 2021. doi: 10.5306/wjco.v12.i6.404
Table 1 Summary of the expression of muscarinic acetylcholine receptor subtypes (M) in different human cancers
Receptor subtypes | Malignant tissue | |
M1 | Skin[142] | Breast[128] |
Brain[131] | Liver[140] | |
Prostate[136] | Esophagus[135] | |
Cervix uteri[139] | Pancreas[147] | |
M2 | Lung[134] | Esophagus[135] |
Brain[143] | Bladder[125] | |
Breast [128] | Leukemia[145] | |
M3 | Lung [124] | Breast[148] |
Colon[133] | Esophagus[135] | |
Skin[142] | Liver[139] | |
Prostate[138] | Stomach[132] | |
Cervix uteri[139] | Leukemia[145] | |
Head and neck[146] | ||
M4 | Brain[131] | Breast[128] |
Prostate[137] | Esophagus[135] | |
Cervix uteri[139] | Oral cavity[141] | |
M5 | Skin[130] | Breast[128] |
Cervix uteri[139] | Esophagus[135] |
- Citation: Español A, Salem A, Sanchez Y, Sales ME. Breast cancer: Muscarinic receptors as new targets for tumor therapy. World J Clin Oncol 2021; 12(6): 404-428
- URL: https://www.wjgnet.com/2218-4333/full/v12/i6/404.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i6.404